OBJECTIVE: To evaluate the incidence, characteristics, and clinical consequences of delayed intraventricular hemorrhage (dIVH). METHODS: Patients with primary intracerebral hemorrhage (ICH) were enrolled into a prospective registry between December 2006 and February 2012. Patients were managed, and serial neuroimaging obtained, per a structured protocol. Initial and delayed IVH were identified on imaging, along with ICH volumes, with outcomes blinded. Multivariate models were developed to test whether the occurrence of dIVH was a predictor of functional outcomes independent of known predictors, including the ICH score elements and ICH growth. RESULTS: A total of 216 patients were studied, and 104 (48%) had IVH on initial imaging. Of the 112 with no IVH, 23 (21%) subsequently developed IVH. Emergent surgical intervention, mostly ventriculostomy placement, was required after discovery of dIVH in 10 (43%) of these 23. In multivariate models adjusting for all elements of the ICH score and hematoma growth, dIVH was an independent predictor of death at 14 days (p = 0.015) and higher modified Rankin Scale scores at 3 months (all p = 0.037). The effect of dIVH remained significant in a secondary analysis that adjusted for all other variables significant in the univariate analysis. CONCLUSIONS: Similar to hematoma expansion dIVH is independently associated with death and poor outcomes. Because IVH is easily detected by serial neuroimaging and often requires emergent surgical intervention, monitoring for dIVH is recommended.
OBJECTIVE: To evaluate the incidence, characteristics, and clinical consequences of delayed intraventricular hemorrhage (dIVH). METHODS:Patients with primary intracerebral hemorrhage (ICH) were enrolled into a prospective registry between December 2006 and February 2012. Patients were managed, and serial neuroimaging obtained, per a structured protocol. Initial and delayed IVH were identified on imaging, along with ICH volumes, with outcomes blinded. Multivariate models were developed to test whether the occurrence of dIVH was a predictor of functional outcomes independent of known predictors, including the ICH score elements and ICH growth. RESULTS: A total of 216 patients were studied, and 104 (48%) had IVH on initial imaging. Of the 112 with no IVH, 23 (21%) subsequently developed IVH. Emergent surgical intervention, mostly ventriculostomy placement, was required after discovery of dIVH in 10 (43%) of these 23. In multivariate models adjusting for all elements of the ICH score and hematoma growth, dIVH was an independent predictor of death at 14 days (p = 0.015) and higher modified Rankin Scale scores at 3 months (all p = 0.037). The effect of dIVH remained significant in a secondary analysis that adjusted for all other variables significant in the univariate analysis. CONCLUSIONS: Similar to hematoma expansion dIVH is independently associated with death and poor outcomes. Because IVH is easily detected by serial neuroimaging and often requires emergent surgical intervention, monitoring for dIVH is recommended.
Authors: J T Lindsay Wilson; Asha Hareendran; Marie Grant; Tracey Baird; Ursula G R Schulz; Keith W Muir; Ian Bone Journal: Stroke Date: 2002-09 Impact factor: 7.914
Authors: Lewis B Morgenstern; J Claude Hemphill; Craig Anderson; Kyra Becker; Joseph P Broderick; E Sander Connolly; Steven M Greenberg; James N Huang; R Loch MacDonald; Steven R Messé; Pamela H Mitchell; Magdy Selim; Rafael J Tamargo Journal: Stroke Date: 2010-07-22 Impact factor: 7.914
Authors: Andrew M Naidech; Borko Jovanovic; Storm Liebling; Rajeev K Garg; Sarice L Bassin; Bernard R Bendok; Richard A Bernstein; Mark J Alberts; H Hunt Batjer Journal: Stroke Date: 2009-05-14 Impact factor: 7.914
Authors: Natalia S Rost; Eric E Smith; Yuchiao Chang; Ryan W Snider; Rishi Chanderraj; Kristin Schwab; Emily FitzMaurice; Lauren Wendell; Joshua N Goldstein; Steven M Greenberg; Jonathan Rosand Journal: Stroke Date: 2008-06-12 Impact factor: 7.914
Authors: Matthew B Maas; Andrew M Naidech; Minjee Kim; Ayush Batra; Edward M Manno; Farzaneh A Sorond; Shyam Prabhakaran; Eric M Liotta Journal: J Stroke Cerebrovasc Dis Date: 2018-01-05 Impact factor: 2.136
Authors: Matthew B Maas; Brandon A Francis; Rajbeer S Sangha; Bryan D Lizza; Eric M Liotta; Andrew M Naidech Journal: Cerebrovasc Dis Date: 2017-01-04 Impact factor: 2.762
Authors: Matthew B Maas; Michael D Berman; James C Guth; Eric M Liotta; Shyam Prabhakaran; Andrew M Naidech Journal: J Stroke Cerebrovasc Dis Date: 2015-07-02 Impact factor: 2.136
Authors: Anna L Romanova; Alexander J Nemeth; Michael D Berman; James C Guth; Eric M Liotta; Andrew M Naidech; Matthew B Maas Journal: J Stroke Cerebrovasc Dis Date: 2014-07-30 Impact factor: 2.136
Authors: Matthew B Maas; Neil F Rosenberg; Adam R Kosteva; Rebecca M Bauer; James C Guth; Eric M Liotta; Shyam Prabhakaran; Andrew M Naidech Journal: Neurology Date: 2013-06-05 Impact factor: 9.910
Authors: Katharine Colton; Christopher T Richards; Peter B Pruitt; Scott J Mendelson; Jane L Holl; Andrew M Naidech; Shyam Prabhakaran; Matthew B Maas Journal: J Stroke Cerebrovasc Dis Date: 2019-12-12 Impact factor: 2.136